OncoTICE® (Bacillus Calmette-Guérin [BCG], Strain TICE®) is indicated for: treatment of primary or relapsing flat urothelial cell carcinoma in situ (CIS) of the urinary bladder

Intravesical TICE BCG has been used as a therapy for, and prophylaxis against, recurrent tumors in patients with carcinoma in situ(CIS) of the urinary bladder, and to prevent recurrence of …

- 2 allée de Vincennes - 54500 Vandœuvre-lès-Nancy - Tél : 03 72 61 04 80 - Fax : 03 72 61 04 81 -Plateforme de formation du réseau NEON

2021年2月10日 · OncoTICE Powder for instillation fluid for intravesical use - Summary of Product Characteristics (SmPC) by Merck Sharp & Dohme (UK) Limited

used as a medicine. OncoTICE® is used to treat bladder cancer. It is also used . revent bladder cancer fro. coming back after bladder surgery. How does OncoTICE® work? On. oTICE® …

OncoTICE: Bacillus Calmette-Guérin (BCG) belongs to the group of cancer-fighting medications known as antineoplastics. BCG is thought to treat cancer in the bladder by stimulating the …

What OncoTICE is used for ulants. These medicines stimulate certain parts of the immun isease. It is also used to prevent the disease from recurring after bladder Ask your doctor if you have …

OncoTICE is indicated for treatment of primary or concurrent carcinoma-in-situ of the urinary bladder and for the prevention of recurrence of high grade and/or relapsing superficial papillary …

OncoTICE® powder for suspension. 2-8 X 108 CFU Tice® BCG. This leaflet was last revised in July 2023. To listen to or request a copy of this leaflet in braille, large print or audio please call, …

2018年9月6日 · Patient Information leaflet ONCOTICE POWDER FOR SUSPENSION 2-8 X 10 8 CFU TICE BCG INFORMATION FOR THE PATIENT READ ALL OF THIS LEAFLET …